PDS Biotechnology
1.30
+0.01
+0.38%
PDSB
08-26 10:06:52(美东时间)
高
1.32
开
1.32
量
11.19万股
总市值
6085.65万
低
1.28
换
0.24%
额
14.63万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
OYang
昨天20:45
#药闻简讯#
$PDS Biotechnology(PDSB)$
公布 VERSATILE-002 头颈部癌症 II 期临床试验的最终总体生存数据
CPS ≥ 1 的患者中位总生存期(mOS)为 39.3 个月——这是与标准治疗方案 pembrolizumab 或 pembrolizumab 联合化疗相比的最佳已发表结果,后者的 mOS 为 17.9 个月。
6赞
PDS Biotechnology(PDSB)
02-28 19:25
$PDS Biotechnology(PDSB)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001140361-25-006377 Act: 33 Size: 554 KB
网页链接
PDS Biotechnology(PDSB)
02-24 21:15
$PDS Biotechnology(PDSB)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-005571 Act: 34 Size: 529 KB
网页链接
PDS Biotechnology(PDSB)
03-27 19:45
$PDS Biotechnology(PDSB)$
8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-25-010575 Act: 34 Size: 269 KB
网页链接
PDS Biotechnology(PDSB)
03-28 04:35
$PDS Biotechnology(PDSB)$
10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001140361-25-010717 Act: 34 Size: 10 MB
网页链接
PDS Biotechnology(PDSB)
07-10 20:15
$PDS Biotechnology(PDSB)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-025409 Act: 34 Size: 549 KB
网页链接
PDS Biotechnology(PDSB)
05-23 04:15
$PDS Biotechnology(PDSB)$
DEFR14A Revised definitive proxy soliciting materials Accession Number: 0001140361-25-020164 Act: 34 Size: 21 KB
网页链接
PDS Biotechnology(PDSB)
05-16 03:35
$PDS Biotechnology(PDSB)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-002256 Act: 34 Size: 10 KB
网页链接
PDS Biotechnology(PDSB)
06-12 06:05
$PDS Biotechnology(PDSB)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-022225 Size: 5 KB
网页链接
PDS Biotechnology(PDSB)
08-15 08:55
$PDS Biotechnology(PDSB)$
SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-003567 Act: 34 Size: 10 KB
网页链接
PDS Biotechnology(PDSB)
08-14 04:45
$PDS Biotechnology(PDSB)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001140361-25-030825 Act: 34 Size: 9 MB
网页链接
PDS Biotechnology(PDSB)
2024-09-16 19:15
$PDS Biotechnology(PDSB)$
8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001140361-24-041102 Act: 34 Size: 202 KB
网页链接
PDS Biotechnology(PDSB)
03-07 21:55
$PDS Biotechnology(PDSB)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-007516 Act: 34 Size: 558 KB
网页链接
PDS Biotechnology(PDSB)
03-04 05:55
$PDS Biotechnology(PDSB)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-006783 Size: 6 KB
网页链接
PDS Biotechnology(PDSB)
06-12 06:05
$PDS Biotechnology(PDSB)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-022227 Size: 5 KB
网页链接
PDS Biotechnology(PDSB)
07-26 06:15
$PDS Biotechnology(PDSB)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-027403 Size: 7 KB
网页链接
PDS Biotechnology(PDSB)
05-28 04:25
$PDS Biotechnology(PDSB)$
S-3 Registration statement under Securities Act of 1933 Accession Number: 0001140361-25-020483 Act: 33 Size: 376 KB
网页链接
PDS Biotechnology(PDSB)
05-14 19:45
$PDS Biotechnology(PDSB)$
8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-25-018800 Act: 34 Size: 264 KB
网页链接
PDS Biotechnology(PDSB)
05-15 04:45
$PDS Biotechnology(PDSB)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001140361-25-018967 Act: 34 Size: 6 MB
网页链接
PDS Biotechnology(PDSB)
06-02 20:15
$PDS Biotechnology(PDSB)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-021032 Act: 34 Size: 553 KB
网页链接